Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide 72 ug in CIC
NCT02291679Phase 3Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of linaclotide in chronic idiopathic constipation (CIC), sponsored by Ironwood Pharmaceuticals. Started Oct 2014; status: completed.
02
Drugs
linaclotide
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT02291679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291679.